ORF3a mutations: an adaptive advantage for SARS-CoV-2 pathogenecity
likely to be responsible for COVID-19 associated morbidity and mortality. Mutations in ORF3a protein could modulate viral pathogenecity by interfering with host immune response and apoptotic pathways

